Monday, April 1, 2019

Stent Rates Revised




Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary
National Pharmaceutical Pricing Authority: New Delhi, the 29th March, 2019

ORDER

SO:…. In continuation of the notifications issued by National Pharmaceutical Pricing Authority,  Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018 and S.O. 1464(E) dated 02.04.2018, regarding the  fixation  of  ceiling  price  of  the  Coronary  Stents as specified in column no. (2) mentioned in the table below; after  considering  the  Wholesale  Price  Index  (WPI)  @  4.2662 percent for the year 2018 over 2017, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2019, as under:
Table
Sl No
Coronary Stents
( Sl No. 31 in Schedule-I of the DPCO, 2013)
Unit
(in Number)
Ceiling Price
(in Rs.)
(1)
(2)
(3)
(4)
1
Bare Metal Stents
1
8,261
2
Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular  Scaffold (BVS)/ Biodegradable Stents
1
30,080
a)    All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 4.2662% for year 2018 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.
b)    The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table.
c)     As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
d)    The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.

 PN/197/65/2019/F / F. No. 8(65)/2019/D.P./NPPA-Div.-II /ALOK RANJAN/ Assistant Director


Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA

No comments:

Post a Comment